Faraz Ali
CEO,
Tenaya Therapeutics
Robert Ang
President & CEO,
Vor Biopharma
Catherine Bollard
Director of the Center for Cancer and Immunology Research,
Children's National Hospital and The George Washington University
Moya Daniels
CEO & Founder,
Gaia BioSciences Solutions
Lisa Deschamps
CEO & Executive Board Member,
AviadoBio
Debbie Drane
SVP, Strategic Projects,
CSL Behring
Matthew Durdy
Chief Executive,
CGT Catapult
George Eastwood
Executive Director,
Emily Whitehead Foundation
Anne-Virginie Eggimann
Chief Regulatory Officer,
Tessera Therapeutics
Miguel Forte
CEO,
Kiji Therapeutics
Audrey Greenberg
Founder,
Center for Breakthrough Medicines
Sadik Kassim
CTO & CSO,
Danaher Genomic Medicines
Brett Kopelan
Executive Director,
Debra of America
Ann Lee
Chief Technology Officer,
Prime Medicine
Anshul Mangal
President,
Project Farma/Precision ADVANCE
Adora Ndu
Chief Regulatory Officer & EVP Portfolio Strategy and Management,
bridgebio
Susan Nichols
CEO,
Propel Biosciences
Karah Parschauer
Chief Legal Officer & EVP,
Ultragenyx
Kinnari Patel
President, Head of R&D & COO,
Rocket Pharma
Jacob Petersen
SVP, Head of Global Nucleic Acid Therapies,
A Novo Nordisk Company
Louise Rodino-Klapac
Executive Vice President, Chief Scientific Officer,
Sarepta Therapeutics
Alberto Santagostino
CEO & President,
AGC Biologics
Laura Sepp-Lorenzino
Scientific Advisory & Former Chief Scientific Officer,
Intellia Therapeutics
Christy Siegel
SVP & US Therapeutic Area Head, Immunology,
Novartis
Manny Simons
CEO & Co-Founder; SVP, Gene Therapy,
Akouos; Eli Lilly
Bob Smith
Venture Partner,
OrbiMed
Devyn Smith
CEO,
Arbor Biotechnologies
Fyodor Urnov
Director, Technology & Translation,
Innovative Genomics Institute
Christopher Vann
SVP, COO,
Autolus Therapeutics
Kristin Yarema
President & CEO,
Poseida Therapeutics
Richard Wilson
SVP, Primary Focus Lead – Genetic Regulation,
Astellas
Ran Zheng
CEO,
Landmark Bio
